3 ML cabotegravir 200 MG/ML Injection
RxNorm concept 2588077, clinical drug (scd). Prescribable name: cabotegravir 600 MG in 3 ML Extended Release Injection.
- RxCUI
- 2588077
- Term type
- Clinical drug (SCD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2588077 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Related concepts
- cabotegravir 200 MG/ML (SCDC, consists of)
- {1 (3 ML cabotegravir 200 MG/ML Injection) / 1 (3 ML rilpivirine 300 MG/ML Injection) } Pack (GPCK, contained in)
- {1 (3 ML cabotegravir 200 MG/ML Injection) / 1 (3 ML rilpivirine 300 MG/ML Injection) } Pack [CABENUVA 600 MG / 900 MG] (BPCK, contained in)
- Injection (DF, has dose form)
- 3 ML cabotegravir 200 MG/ML Injection [Apretude] (SBD, has tradename)
Linked data
NDCs
- 49702023801
- 49702023861
- 49702023864
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 2588077 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2588077 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2588077. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.